Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

CBX-12 is under clinical development by Cybrexa and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...

A groundbreaking therapy first introduced by Northwestern University researchers in 2021 has shown promise in regenerating ...

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

We asked board-certified dermatologist Dr. Dhaval Bhanusali for his 10 favorite skin-care products and top skin-care tips and tricks.

In preclinical trials on a murine model of breast cancer, the hydrogel showcased remarkable efficacy, the scientists said.

Crinetics Pharmaceuticals is set for a fall 2025 launch of paltusotine, with strong Wall Street support despite being ...

A team of scientists from Indian Institute of Technology (IIT) Guwahati and Bose Institute Kolkata has developed an advanced ...

Researchers at IIT Guwahati and Bose Institute Kolkata have developed an innovative injectable hydrogel for targeted breast cancer therapy. This breakthrough enables precise drug delivery to tumours, ...

Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy ...

cuet pg syllabus 2024 New targeted therapy for cancer treatment! How much do you know about peptide-drug conjugates (PDC)? Novartis/Genentech's Xolair gets FDA approval for new indication To ...